Publications by authors named "Maya Oli"
Lancet Reg Health Eur
August 2024
Article Synopsis
- Clinical trials are essential for determining the safety and effectiveness of drugs and vaccines, but they typically take over ten years; however, recent global health emergencies like COVID-19 have shown that these trials can be accelerated.
- A study analyzed drugs targeting infectious diseases authorized by the European Medicines Agency from 2012 to 2022, finding a median clinical development time of 7.3 years, but significantly shorter times for COVID-19 (1.3 years) and Ebola (5.5 years).
- Key factors for faster development included the outbreak context, which reduced time by an average of 5.4 years, and the use of accelerated assessment by the EMA, leading to additional time savings.
